טוען...
Randomized Trial Assessing the Effects of Ergocalciferol Administration on Circulating FGF23
BACKGROUND AND OBJECTIVES: Fibroblast growth factor 23 is a phosphate- and vitamin D–regulating hormone. The objective of this study was to determine the effect of ergocalciferol administration on fibroblast growth factor 23 levels in healthy vitamin D–deficient subjects. DESIGN, SETTING, PARTICIPAN...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Nephrology
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3315336/ https://ncbi.nlm.nih.gov/pubmed/22300739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.10030911 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|